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Summary
 
Linker for activation of T cells (LAT) is an adaptor protein whose tyrosine phosphorylation is
critical for transduction of the T cell receptor (TCR) signal. LAT phosphorylation is accom-
plished by the protein tyrosine kinase ZAP-70, but it is not at all clear how LAT (which is not
associated with the TCR) encounters ZAP-70 (which is bound to the TCR). Here we show
that LAT associates with surface CD4 and CD8 coreceptors and that its association is promoted
by the same coreceptor cysteine motif that mediates Lck binding. In fact, LAT competes with
Lck for binding to individual coreceptor molecules but differs from Lck in its preferential asso-
ciation with CD8 rather than CD4 in CD4
 
1
 
CD8
 
1
 
 thymocytes. Importantly, as a consequence
of LAT association with surface coreceptors, coengagement of the TCR with surface corecep-
tors induces LAT phosphorylation and the specific recruitment of downstream signaling medi-
ators to coreceptor-associated LAT molecules. These results point to a new function for CD4
and CD8 coreceptors in TCR signal transduction, namely to promote LAT phosphorylation
by ZAP-70 by recruiting LAT to major histocompatibility complex–engaged TCR complexes.
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A
 
ctivation of T lymphocytes in response to antigenic
stimulation is initiated by interaction of surface TCRs
with antigenic peptides bound to MHC molecules. Inside the
cell, TCR engagement of MHC–peptide complexes results
 
in activation of src family protein tyrosine kinases (PTKs)
 
1
 
p56
 
lck
 
 (Lck) and p59
 
fyn
 
 to phosphorylate specialized signal-
ing motifs (referred to as immunoreceptor tyrosine-based
activation motifs [ITAMs]) that are present in the cytosolic
tails of the invariant components of surface TCR complexes
(1–4). Phosphorylated ITAMs then recruit ZAP-70 to sur-
face TCR complexes, whereupon the recruited ZAP-70
molecules are themselves tyrosine phosphorylated and acti-
vated (5–10). These proximal TCR signaling events are
significantly enhanced by MHC-induced coengagement of
TCR with surface CD4/CD8 coreceptor molecules, since
such coengagement serves to juxtapose TCR complexes
with coreceptor-associated Lck molecules and so promotes
efficient phosphorylation of TCR ITAMs (11, 12) and effi-
cient activation of TCR-associated ZAP-70 PTK molecules
(13). Further propagation of the TCR signal requires tyro-
sine phosphorylation by ZAP-70 of linker for activation of
T cells (LAT), a 36/38-kd membrane-associated protein that,
upon tyrosine phosphorylation, is subsequently bound by
downstream signaling mediators (14–16). Thus, tyrosine
phosphorylation of LAT marks the transition between prox-
imal and downstream signaling events initiated by TCR en-
gagement of MHC–peptide complexes.
Because of LAT’s central role in TCR signal transduc-
tion, it is important to understand how TCR-associated
ZAP-70 PTK molecules encounter LAT in order to tyro-
sine phosphorylate it. In this study, we examined the possi-
bility that LAT, like Lck, might be associated with CD4
and CD8 coreceptor molecules and so might be colocalized
with TCR-associated ZAP-70 molecules upon MHC-
induced coengagement of the TCR with CD4/CD8 core-
ceptors. We report that LAT does associate with CD4 and
CD8 coreceptors in T cells, and that coengagement of TCR
with surface coreceptor molecules induces LAT phosphor-
ylation and recruitment of downstream signaling mediators
to coreceptor-associated LAT molecules.
 
1
 
Abbreviations used in this paper:
 
 GEM, glycolipid-enriched membrane mi-
crodomain; ITAM, immunoreceptor tyrosine-activated motif; LAT,
linker for activation of T cells; PI-3, phosphatidylinositol-3; PLC, phos-
pholipase C; PTK, protein tyrosine kinase; SH2, src homology 2. 
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Materials and Methods
 
Cell Preparation and Immunoprecipitations.
 
The care of experi-
mental animals was in accordance with National Institutes of Health
guidelines. Single cell suspensions of lymph node cells and thy-
mocytes were prepared from C57BL/6 or CD8
 
b
 
2
 
 mice thymi.
Purified populations of CD4
 
1
 
CD8
 
1
 
 thymocytes 
 
.
 
96% pure
were obtained by anti-CD8 panning of whole thymocyte popu-
lations and selecting the adherent cells, as described previously
(17). Cells (0.5–3 
 
3 
 
10
 
8
 
, as indicated) were lysed in ice-cold lysis
buffer containing either 1% Triton X-100 or 60 mM octylgluco-
side. After clarification (10,000 
 
g
 
 for 10 min), cell lysates were
subjected to immunoprecipitation with the indicated antibodies.
Immunoprecipitates were resolved on SDS-PAGE under reducing
conditions. Antibodies used for immunoprecipitation were specific
for: CD4 (GK1.5 or RM4.5; PharMingen), CD8
 
a
 
 (53-6-7; Phar-
Mingen), or CD8
 
b
 
 (53-5.8; PharMingen); and TCR-
 
z
 
 (serum
551), Lck (serum 688), or LAT (serum 3023) (14). Antibodies
used for immunoblotting were specific for: LAT (serum 3023);
Lck (serum 688); or phosphotyrosine (4G10; Upstate Biotech-
nology). For immunoprecipitations, mAbs were directly coupled
to CnBr-activated Sepharose beads (Amersham Pharmacia Biotech),
except when indicated otherwise.
 
Thymocyte Stimulation.
 
Pervanadate treatment (final concen-
tration of 0.01 mM Na
 
3
 
VO
 
4
 
 in the presence of 4.5 mM H
 
2
 
O
 
2
 
,
extemporaneously prepared) was conducted for 10 min at 37
 
8
 
C.
TCR cross-linking experiments were performed essentially as de-
scribed (13). Antibodies used for cross-linking were as follows:
anti–TCR-
 
b
 
 (H57-597 [18]), anti-CD4 (GK 1.5; PharMingen),
and anti-CD8
 
a
 
 (2.43 [19] or 53-6.7 [PharMingen]). Thymocytes
were cultured for 18 h at 37
 
8
 
C, pelleted, and resuspended at 10
 
7
 
/ml
in ice-cold RPMI containing 1 mM Na
 
3
 
VO
 
4
 
 and biotinylated
antibodies (10 
 
m
 
g/ml). After 10 min at 4
 
8
 
C, the cells were pel-
leted and resuspended at 10
 
8
 
/ml in RPMI containing 20 
 
m
 
g/ml
of streptavidin (Southern Biotechnology Associates) previously
prewarmed at 37
 
8
 
C. After a 5-min incubation at 37
 
8
 
C, cells were
pelleted and lysed in octylglucoside-containing buffer.
 
DNA Constructs and Transfections.
 
cDNAs encoding mouse CD4,
CD8
 
a
 
, and CD8
 
b
 
 were provided by Dr. Jane Parnes (Stanford
University, Stanford, CA [20]). Fragments encoding each core-
ceptor domain, or mutant derivatives thereof, were prepared by
restriction enzyme digestion, PCR amplification, or as double
stranded oligonucleotides, and ligated to generate the indicated
constructs. The CD8
 
a
 
 AAM mutation, converting cysteines 227
and 229 to alanines, was introduced using PCR-mediated site-
directed mutagenesis (21). Amino acid sequences (single letter
code) at the modified junctions were as follows: ABB, LDFACD/
ITTLSL; AAT, LICYA/RSR; ABA, LDFACD/ITTLSL . . .
VYFYCA/RSRKRVC; 4AA, GVNQTD/IYIWAPL; 4BB,
GVNQTD/ITTLSL. The sequences of all PCR-amplified and
oligonucleotide-encoded regions were verified by dideoxy sequenc-
ing for the presence of the desired modifications and the absence
of additional mutations. Wild-type and mutant cDNAs were in-
troduced in pcDNA3 (Invitrogen) for expression in 293T cells.
Expression vectors for mouse and human LAT have been de-
scribed (14, 22). 293T cells were transfected using the calcium
phosphate coprecipitation method (23). Total plasmid amount
was kept constant among samples by adjusting the amount of empty
expression vectors. Cells were harvested 36–40 h after transfec-
tion. Expression of the coreceptor derivatives in each sample was
verified by cell surface staining with anti-CD4 (GK 1.5), anti-
CD8
 
a
 
 (53-6.7), and anti-CD8
 
b
 
 (53-5.8) mAbs and cytofluori-
metric analysis.
 
Results
 
To determine if coreceptor–LAT complexes existed on
unstimulated murine T cells and thymocytes, we immuno-
blotted anti-CD4 and anti-CD8 immunoprecipitates for
LAT (Fig. 1 A, left). In lymph node T cells that express
CD4 and CD8 coreceptors on separate cell populations, we
found that LAT was associated with both CD4 and CD8
(Fig. 1 A, lanes 2 and 3). In immature CD4
 
1
 
CD8
 
1
 
 thymo-
cytes, which express both CD4 and CD8 on individual
cells, we found that LAT associated with CD8 in signifi-
Figure 1. Association of LAT with CD4 and CD8 coreceptors in mature T cells and immature thymocytes. (A) Mouse lymph node cells (3 3 108 cell
equivalents/lane) or thymocytes (0.5 3 108 cell equivalents/lane) were detergent solubilized by 1% Triton X-100 (lanes 1–8) or 60 mM octylglucoside
(OCT, lanes 9–13), and the resulting lysates were immunoprecipitated with either anti-CD4 or anti-CD8a mAbs directly coupled to beads. Unfraction-
ated cell lysates (3–6 3 106 cell equivalents/lane) and immunoprecipitates (ip) were resolved by SDS-PAGE, immunoblotted with a LAT-specific rabbit
antiserum, and visualized by enhanced chemiluminescence. In contrast to anti-CD4 and anti-CD8a immunoprecipitates, which contained LAT, control
anti-z immunoprecipitates did not contain LAT (data not shown). As additional negative specificity controls, antibody-coupled beads in the absence of
lysate were also immunoblotted for LAT (lanes 4 and 5). In lanes 10–13, anti-CD8a immunoprecipitates and unfractionated cell lysates from CD8b2
thymocytes were assessed for LAT and compared with wild-type CD8b1 thymocytes. (B) Mouse thymocytes were lysed in 60 mM octylglucoside, im-
munoprecipitated (ip) with anti-CD4 or anti-CD8 mAb directly coupled to beads, and immunoblotted with either anti-Lck or anti-LAT. LAT was pref-
erentially immunoprecipitated by CD8, whereas Lck was preferentially immunoprecipitated by CD4 (lanes 1 and 2). As an additional specificity control,
neither LAT nor Lck was immunoprecipitated by beads in the absence of anti-CD4 or anti-CD8 antibodies (lane 3). 
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cantly greater amounts than with CD4 (Fig. 1 A, lanes 6 and
7). Interestingly, the hierarchy of LAT binding in imma-
ture CD4
 
1
 
CD8
 
1
 
 thymocytes (CD8
 
 . 
 
CD4) is reciprocal
to Lck, which binds CD4
 
 . 
 
CD8 (24, 25; Fig. 1 B).
We then analyzed CD8–LAT associations in thymocytes
in greater detail. LAT molecules are largely localized to
detergent-resistant areas of the plasma membrane referred
to as glycolipid-enriched membrane microdomains (GEMs
[22, 26]), which also contain subpopulations of both CD4
and CD8 molecules (27). Thus, it was conceivable that coim-
munoprecipitation of LAT with CD4/CD8 coreceptors
might simply reflect the presence of LAT and CD4/CD8
coreceptors in the same GEM. This was not the case, how-
ever, as LAT–CD8 associations were maintained in anti-
CD8 immunoprecipitations of cells solubilized by the deter-
gent octylglucoside, which solubilizes GEMs (28, 29; Fig.
1 A, lanes 8 and 9). In fact, detergent solubilization with
octylglucoside increased the amount of LAT detected in
anti-CD8 immunoprecipitates (Fig. 1 A, lanes 8 and 9).
Next, we assessed whether LAT association with CD8
required both components of CD8 (
 
a
 
 and 
 
b
 
). In normal
mice, CD8 is expressed on thymocytes and thymic-derived
T cells as an 
 
ab
 
 heterodimer, whereas in CD8
 
b
 
2
 
 mice,
CD8 is expressed as an 
 
aa
 
 homodimer (30, 31). Despite
similar amounts of LAT in whole cell lysates from normal
and CD8
 
b
 
2
 
 thymocytes (Fig. 1 A, lanes 12 and 13), the
amount of CD8-associated LAT was markedly greater in
CD8
 
b
 
1
 
 thymocytes than in CD8
 
b
 
2
 
 thymocytes, although
a small amount of LAT binding to CD8
 
aa
 
 homodimers
was evident in CD8
 
b
 
2
 
 thymocytes (Fig. 1 A, lanes 10 and
11). Thus, CD8
 
b
 
 contributes to CD8–LAT association, as
it does to CD8–Lck association (32, 33). For Lck, CD8
 
b
 
 is
thought to increase accessibility to a binding site present in
the cytosolic tail of CD8
 
a
 
, and this may be the case for
LAT as well.
To determine the molecular basis for LAT–coreceptor
associations, we cotransfected 293T cells, a human trans-
formed kidney cell line expressing SV40 T antigen, with
murine LAT (mLAT) and murine coreceptor molecules
(CD8
 
a
 
 and 
 
b
 
 or CD4). The transfected coreceptor mole-
cules were either wild-type or variants containing altered
transmembrane or cytosolic domains (Fig. 2 A). Surface ex-
pression of transfected coreceptor molecules was quantitated
by immunofluorescence and flow cytometry and was found
to be similar within all experimental groups (Table I). Ly-
sates from transfected 293T cells were immunoprecipitated
by anti-CD8
 
a
 
 mAbs (Fig. 2 B, left) or anti-CD4 mAb (Fig.
2 B, right), and the immunoprecipitates were immunoblot-
ted for LAT. Both CD8–LAT and CD4–LAT complexes
were observed in 293T cells transfected with intact (AAA,
444) coreceptor molecules (Fig. 2 B, lanes 3 and 13), dem-
onstrating that coreceptor–LAT complexes could form in
nonlymphoid cells and did not require Lck, which is not
expressed in 293T cells. We further documented that LAT
did not associate with CD4 or CD8
 
a
 
 variants expressing
either the cytosolic tail of CD8
 
b
 
 (lanes 4 and 12) or lacking
a cytosolic tail altogether (lanes 5 and 9). Thus, the cyto-
solic tails of CD4 and CD8
 
a
 
 are the main determinants for
LAT association, suggesting that a sequence common to
both cytosolic tails is involved in LAT binding.
Sequence homology between the cytosolic domains of
CD4 and CD8
 
a
 
 is restricted to a short region centered
around a CxC cysteine motif that is involved in Lck bind-
ing (34, 35). To examine the possible role of this cytosolic
CxC cysteine motif in LAT–coreceptor associations, we
constructed a CD8
 
a
 
 variant (AAM) in which both cyto-
solic cysteines C227 and C229 were mutated to alanines (Fig.
2 A). We found that substitution with alanine of these two
cysteines diminished CD8
 
a
 
 associations with murine LAT
by 70% (Fig. 2 B, compare lanes 8 and 10). Thus, the cyto-
solic CxC cysteine motif important for coreceptor associa-
tions with Lck is also important for coreceptor associations
with LAT.
Because LAT molecules contain two molecular species
that migrate at either 36 or 38 kD in SDS-PAGE (14, 22),
we wished to determine if coreceptors preferentially associ-
ated with one or the other form of LAT. To address this is-
sue, we used human LAT (hLAT) because the 36- and
38-kD forms of hLAT are easily distinguishable (Fig. 2 C,
lysate). We found that CD8 coreceptors were associated al-
most exclusively with the lower 36-kD form of LAT, and
that that association was dependent on the cytosolic cys-
teines in the CD8
 
a
 
 tail (Fig. 2 C, lanes 1–3). However, ap-
pearance of the lower 36-kD form of hLAT is dependent
on two juxtamembrane cysteines (C26, C29) in the cyto-
solic tail of hLAT, which are palmitoylated and responsible
for targeting LAT molecules to GEMs (22). Alanine substi-
tution of both cysteines (C26/29A) removes the palmitoyla-
tion sites and results in migration of LAT as a single 38-kD
(upper) band (Fig. 2 C, lanes 4 and 5). Interestingly, despite
the fact that the C26/29A mutant LAT molecule cannot be
palmitoylated and targeted to GEMs, we found that the
mutant LAT can still associate with surface CD8 coreceptor
molecules (Fig. 2 C, lanes 4 and 5). These results confirm
that CD8–LAT associations are the result of specific pro-
tein–protein interactions and not simply of colocalization
of both molecules in GEMs. However, we do not yet un-
derstand why CD8 normally preferentially associates with
the lower band of LAT when it is also clearly capable of
binding to the upper band.
Since the cytosolic cysteine motif in CD8
 
a
 
 promotes
binding of LAT as well as Lck, we considered that LAT and
Lck might compete for binding to individual coreceptor
molecules. To address this issue, we transiently expressed
CD8
 
a
 
, CD8
 
b
 
, and mLAT in 293T cells. In addition, we
also transfected the cells with an excess of either Lck-con-
taining vector or empty vector (Fig. 3). Even though Lck
did not affect the amount of LAT present in the cell lysates,
Lck abrogated the ability of LAT to be immunoprecipitated
by anti-CD8
 
a
 
 (Fig. 3). Thus, Lck protein, when present in
excess, competes with LAT for binding to CD8.
Since LAT function in TCR signal transduction depends
on its tyrosine phosphorylation, we examined the ability of
coreceptor-associated LAT molecules to be tyrosine phos-
phorylated. Treatment of thymocytes with pervanadate to
induce activation of intracellular protein tyrosine kinases (36) 
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resulted in tyrosine phosphorylation of CD8-associated
LAT and recruitment of LAT-binding phosphoproteins (Fig.
4 A) previously identified to include phospholipase C
(PLC)-
 
g
 
1 and Cbl, among others (14). Tyrosine phosphor-
ylation of coreceptor-associated LAT molecules was also in-
duced in thymocytes by antibody-mediated coengagement
of TCR with either CD4 or CD8, but was not induced by
TCR engagement alone (Fig. 4 B, lanes 1–6). Coengage-
ment of TCR with either CD4 or CD8 also resulted in the
appearance of phosphoprotein bands indicative of PLC-
 
g
 
1
and Cbl (Fig. 4 B, lanes 7–12). Importantly, formation of
oligomeric signaling complexes on coreceptor-associated
LAT molecules occurred with a remarkable degree of spec-
ificity, preferentially forming on coreceptor-associated LAT
molecules that had been coengaged with TCR, compared
with LAT molecules that had not been coengaged with TCR.
That is, PLC-
 
g
 
1 and Cbl were preferentially recruited to
CD4-associated LAT molecules by coengagement of TCR
with CD4 compared with coengagement of TCR with CD8
(Fig. 4 B, lanes 7–9); and, reciprocally, PLC-
 
g
 
1 and Cbl
were preferentially recruited to CD8-associated LAT mole-
cules by coengagement of TCR with CD8 compared with
coengagement of TCR with CD4 (Fig. 4 B, lanes 10–12).
The small amount of phosphorylated Cbl that was immu-
noprecipitated by antibodies specific for the nonengaged
coreceptor probably reflects the passive and inadvertent
capture of some nonengaged coreceptor molecules within
the TCR aggregate (Fig. 4 B, lanes 9 and 11). Thus, corecep-
Figure 2. Mapping the coreceptor site for LAT association. (A) Schematic of the coreceptor
derivatives used in this study. Mouse CD8a (AAA), CD8b (BBB), and CD4 (444) molecules
(references 20 and 44) are schematically depicted by gray, hatched, or white bars and designated
by a three-letter code indicating the origin of their extracellular, transmembrane (tmb), and in-
tracellular domains. In addition to intact coreceptor molecules (AAA, BBB, 444), we con-
structed variant coreceptor molecules either lacking a cytosolic tail (AAT) or containing shuffled
coreceptor domains. A mutant CD8a construct (AAM) was also generated by mutating to ala-
nines the cytosolic cysteines at positions 227 and 229 of CD8a. (B) 293T kidney cells were
cotransfected with the indicated expression vectors and analyzed 36–40 h after transfection for
coreceptor–LAT associations. CD8 transfections involved cotransfection with both CD8a and
CD8b vectors in addition to LAT, whereas CD4 transfections only involved cotransfection with
CD4 and LAT. Cells were detergent solubilized with Triton X-100; identical results were ob-
tained with cells detergent solubilized with octylglucoside. Anti-CD8a immunoprecipitations
(ip, left) were performed with anti-CD8a mAb covalently coupled to Sepharose beads, and two
independent experiments are shown (lanes 1–6 and lanes 7–10). Anti-CD4 immunoprecipita-
tions (right) were performed using anti-CD4 mAb adsorbed onto protein G–Sepharose beads
(Pr. G, lanes 11–13). As a negative control for anti-CD4 immunoprecipitations, cell lysates were
immunoprecipitated with protein G–Sepharose beads alone without anti-CD4 mAb (lane 14).
Assessment of unfractionated cell lysates revealed that transfected cells within each experiment
expressed essentially equivalent amounts of LAT (lower panel), although they differed in the
amount of LAT present in anti-coreceptor immunoprecipitations (upper panel). In addition,
surface expression of coreceptor molecules in each cell transfection was quantitated by immu-
nofluorescence and flow cytometry (see Table I). Densitometric analysis of the films indicated that the amount of AAM-bound LAT (lane 10) was 30% of
the amount of AAA-bound LAT (lane 8). Essentially identical results were also obtained using 125I-labeled protein A instead of chemiluminescence to vi-
sualize LAT. (C) Association of hLAT with CD8. 293T cells were cotransfected with wild-type (AAA) or mutant (AAM) versions of CD8a, wild-type
(hLAT) or mutant (C26/29A) versions of human LAT, and CD8b. Cells were solubilized in octylglucoside, immunoprecipitated, and resolved by SDS-
PAGE. In lanes 1–3, wild-type LAT migrated as two bands of 36 and 38 kD. However, wild-type CD8a preferentially associated with the lower 36-kD
band (lane 2); in contrast, the AAM mutant of CD8a bound neither band well. In lanes 4–5, it can be seen that the C26/29A mutant of human LAT (in
which cysteines 26 and 29 were mutated to alanines) migrated as a single band of 38 kD that could still associate with CD8. Relative fluorescence intensities
(as defined in Table I) for anti-CD8a immunostaining of transfected cells were ,0.01 (cells in lanes 1 and 4), 1.0 (lane 2), 0.7 (lane 3), and 0.9 (lane 5).1521 Bosselut et al.
tors can promote LAT phosphorylation by TCR-associated
ZAP-70 molecules and the subsequent recruitment of down-
stream signaling mediators.
Discussion
This study demonstrates that the LAT adaptor molecule
associates with CD4 and CD8 surface coreceptors, and that
such coreceptor associations are mutually exclusive with
Lck. Indeed, the site on the cytosolic tail of CD4 and
CD8a coreceptors to which LAT binds overlaps the site to
which Lck binds, resulting in competition between Lck
and LAT for coreceptor binding. Because of their associa-
tion with coreceptor molecules, LAT molecules would be
juxtaposed with TCR complexes upon coengagement of
MHC–peptide complexes. In fact, we found that oligomeric
complexes of downstream signaling mediators preferen-
tially formed on those LAT molecules that were associated
with coreceptors coengaged with the TCR. Thus, this study
provides one solution to the problem of how TCR-asso-
ciated ZAP-70 molecules can efficiently find their LAT
substrate.
Colocalization of LAT with TCR would be a second
function performed by CD4 and CD8 coreceptor mole-
cules in TCR signal transduction, with colocalization of
Lck and TCR being the only previously known function.
In fact, we think that the two coreceptor functions are
analogous to one another, in that coengagement of TCR
with CD4 or CD8 coreceptor molecules by MHC–peptide
complexes serves to physically juxtapose both Lck and LAT
with TCR (schematized in Fig. 5). As a result, coreceptors
promote both the initiation of TCR signaling and the acti-
vation of downstream signaling mediators. It is tempting to
consider the implications of our present observations on
the distinct but overlapping roles performed by CD4 and
CD8 coreceptors in promoting TCR signal transduction in
immature CD41CD81 thymocytes during T cell develop-
ment in the thymus, as CD4 engagement by intrathymic
MHC class II molecules would preferentially promote Lck
activation (25), whereas CD8 engagement by intrathymic
MHC class I molecules would preferentially promote LAT
phosphorylation and activation of downstream mediators.
It is conceivable that such coreceptor-induced differences
in TCR signal transduction pathways influence lineage
choices, but this possibility has not yet been examined. Un-
fortunately, LAT knockout mice have not been informa-
tive for this issue, as the absence of LAT arrests thymocyte
development at an early CD42CD82 stage of development
that precedes expression of CD4 and CD8 coreceptors as
well as the point at which CD4/CD8 lineage determina-
tion occurs (37).
The association of LAT with surface CD4 and CD8
coreceptor molecules provides one solution to the problem
of how TCR-associated ZAP-70 molecules manage to con-
tact and phosphorylate LAT molecules. Indeed, we found
that association of LAT with CD4 and CD8 coreceptors
Table I. Coreceptor Expression in Transfected 293T Cells
Exp. Sample*
Coreceptor
derivative
Mean
fluorescence
intensity Relative
fluorescence
intensity CD8a CD4
1 1 AAA 195 1.0
2– 1 ,0.01
3 AAA 183 0.9
4 ABB 103 0.6
5 AAT 346 1.8
6 ABA 265 1.4
27– 1 ,0.01
8 AAA 702 1.0
9 AAT 528 0.8
10 AAM 536 0.8
3 11 4AA 319 1.3
12 4BB 269 1.1
13 444 248 1.0
14 444 248 1.0
Surface expression of transfected coreceptor molecules on 293T kidney
cells from Fig. 2 B was quantitated by surface staining with either anti-
CD8a (experiment [Exp.] 1 and 2) or anti-CD4 (experiment 3) mAbs
and flow cytometry. Surface staining of transfected cells was unimodal,
and mean fluorescence intensities (expressed in fluorescence units) are
indicated for each construct. Within each experiment, mean fluores-
cence intensity was normalized for each construct relative to that of the
wild-type coreceptor construct (either AAA or 444), whose relative
fluorescence intensity was set at 1.0.
*Sample numbers refer to lane numbers in Fig. 2 B.
Figure 3. Overexpression of Lck inhibits CD8–LAT association in
293T cells. 293T cells were transfected with CD8a, CD8b, and mLAT,
and either an Lck expression vector (10-fold excess over the mLAT vec-
tor, lane 1) or the same amount of empty control vector (lane 2). Expres-
sion of Lck did not detectably change either total LAT expression or sur-
face CD8 expression (data not shown). However, overexpression of Lck
resulted in CD8–Lck associations and in the inhibition of CD8–LAT as-
sociations. Relative fluorescence intensities (as defined in Table I) for
anti-CD8a immunostaining of cells in lane 1 and 2 were identically 1.0.1522 LAT Association with CD4 and CD8 Coreceptors
was of functional significance for TCR signal transduction,
as: (a) coreceptor-associated LAT molecules were tyrosine
phosphorylated upon TCR–coreceptor coengagement, and,
more importantly, (b) the scaffold for oligomerization of
downstream signaling mediators preferentially formed on
coreceptor-associated LAT molecules that were coengaged
with TCR. Thus, coreceptor-induced colocalization of LAT
with TCR promotes downstream TCR signaling events.
We found that coreceptor–LAT associations are pro-
moted by the same dicysteine motif in the coreceptor tails
that promotes Lck binding. Nevertheless, we do not think
that Lck and LAT bind to coreceptor molecules through
identical mechanisms. Association of coreceptor molecules
with Lck involves formation of a zinc-dependent complex
between the dicysteine motif in the coreceptor tail and two
cysteines in Lck (38), and strictly requires those cysteines to
be present in both the coreceptor tail and the Lck molecule
(34, 35). In contrast, association of coreceptor molecules
with LAT does not require cysteines in LAT, as CD8–LAT
interactions were not abolished by mutation of LAT dicys-
teines to alanines. In fact, association of coreceptor mole-
cules with LAT also does not strictly require the presence
of the dicysteine motif in the coreceptor tail, as mutation of
these coreceptor cysteines did not abrogate (but significantly
reduced) association with LAT. Thus, we think that the
molecular basis for LAT–coreceptor association is distinct
from that of Lck–coreceptor association despite their over-
lapping binding sites. That Lck and LAT actually bind to
overlapping sites in the cytosolic tail of CD8a is indicated
by cotransfection experiments in which Lck was found to
disrupt LAT binding to CD8. Such mutual exclusivity of
binding may account for the opposite coreceptor binding
preferences of LAT and Lck in CD41CD81 thymocytes,
such that LAT may be primarily associated with CD8 be-
cause Lck is primarily associated with CD4. However, we
favor the possibility that Lck and LAT have intrinsically
different binding preferences for CD4 and CD8 coreceptor
molecules such that Lck binds CD4 . CD8 and LAT binds
CD8 . CD4.
LAT molecules are normally palmitoylated and, as a
consequence, localized to GEMs (22). Importantly, how-
ever, LAT–coreceptor associations are mediated through
protein–protein interactions and do not simply reflect their
colocalization in GEMs, as LAT–coreceptor associations
occur even in the absence of LAT palmitoylation. Indeed, a
nonpalmitoylated version of LAT (C26/29A LAT) which
Figure 4. Tyrosine phosphorylation of coreceptor-associated LAT molecules and recruitment of
downstream signaling intermediates. (A) Octylglucoside-solubilized lysates from thymocytes stimulated
with medium or sodium pervanadate (perv.) were immunoprecipitated (ip), resolved on SDS-PAGE, and
immunoblotted with antiphosphotyrosine (anti-pY, upper panel) or anti-LAT (lower panel) antibodies.
Molecular weight markers are indicated. Black arrowheads point to phosphotyrosyl proteins found in both anti-LAT and anti-CD8a immunoprecipi-
tates. White arrowhead indicates a phosphotyrosyl protein associated to total LAT, but not detectably present in this CD8a immunoprecipitate. None of
these phosphotyrosyl bands were observed in immunoprecipitates prepared in the absence of specific antibody. The 50-kD band in lanes 3 and 4 is Ig H
chain from the precipitating antibody. (B) Coengagement of TCR with surface coreceptor molecules results in tyrosine phosphorylation of coreceptor-
associated LAT molecules and specific recruitment of downstream signaling intermediates. Cultured thymocytes were stimulated either by TCR cross-
linking, or by TCR plus CD4 cocross-linking or TCR plus CD8 cocross-linking and detergent solubilized with octylglucoside. Lysates were immuno-
precipitated with either anti-CD4 plus protein G–Sepharose (lanes 1–3) or anti-CD8 plus protein G–Sepharose (lanes 4–6). Because protein G–Sepharose
may bind and precipitate the anti-TCR and anti-coreceptor mAbs used for signaling, we did not use protein G–Sepharose to assess the molecular speci-
ficity of TCR plus coreceptor cocross-linking. Rather, we used coreceptor-specific mAbs directly coupled to beads (lanes 7–12). Importantly, the immu-
noprecipitating coreceptor mAbs we coupled to beads were specific for different epitopes on CD4 and CD8 than those used for surface cross-linking so
that the stimulating antibodies would not interfere with coreceptor immunoprecipitations. Immunoprecipitates were resolved by SDS-PAGE and immu-
noblotted with either antiphosphotyrosine (anti-pY) or anti-LAT antibodies. The positions of two phosphoproteins of 140 and 120 kD, corresponding by
molecular mass to phosphorylated (circled P) PLC-g1 and Cbl, are indicated (lanes 7–12). TCR plus CD4 cocross-linking resulted in preferential recruit-
ment and phosphorylation of these proteins to CD4-associated LAT molecules (lanes 7–9), and, reciprocally, TCR plus CD8 cocross-linking resulted in
preferential recruitment and phosphorylation of these proteins to CD8-associated LAT molecules (lanes 10–12).1523 Bosselut et al.
does not localize in GEMs still associated with CD8. Nev-
ertheless, it should be appreciated that subpopulations of
CD4 and CD8 coreceptor molecules are normally present
in GEMs (27), perhaps as a result of their association with
palmitoylated LAT molecules. Consistent with such a pos-
sibility, we found that detection of CD8–LAT complexes
was significantly increased by solubilization of cells with the
detergent octylglucoside, which solubilizes GEMs far better
than the detergent Triton X-100.
Surface CD4/CD8 coreceptors are not strictly required
for TCR signal transduction, as CD42CD82 T cells, in the
absence of either CD4 or CD8 coreceptor molecules, com-
petently transduce TCR signals. Consequently, there must
exist coreceptor-independent mechanisms for promoting
LAT phosphorylation by ZAP-70, although they may be less
efficient than the physical colocalization resulting from LAT
association with surface coreceptor molecules. It is conceiv-
able that trapping of GEM-associated LAT molecules be-
tween aggregated TCR complexes can induce LAT phos-
phorylation. Such a possibility is suggested by the finding
that TCR stimulation results in the migration of TCR
components into GEMs (39, 40). Importantly, however, it
is not at all clear that ZAP-70 actually translocates to GEMs,
a necessary event for ZAP-70 phosphorylation of GEM-
associated LAT, as conflicting results have been reported (22,
39, 40). In any event, the inadvertent trapping of LAT be-
tween TCR aggregates would be expected to be signifi-
cantly less efficient than the juxtaposition of LAT and TCR
induced by coengagement of MHC–peptide complexes.
It has been suggested that LAT phosphorylation by
ZAP-70 may be enhanced by proteins containing Src ho-
mology 2 (SH2) domains such as 3BP2, phosphatidylinosi-
tol-3 (PI-3) kinase p85 regulatory subunit, or PLC-g1.
3BP2 is an SH2-containing adaptor protein that binds to
tyrosine-phosphorylated forms of LAT and ZAP-70 (41).
Because 3BP2 contains only one SH2 domain, it is not ev-
ident how it could couple activated ZAP-70 to LAT. PI-3
kinase p85 subunit is a protein that contains two SH2 do-
mains and has been shown in platelets to couple tyrosine-
phosphorylated LAT with other tyrosine-phosphorylated
molecules such as FcR g chain (42). Similarly, PLC-g also
has two SH2 domains and could conceivably couple ZAP-70
to LAT (43). However, because SH2 domain–containing
linker proteins only bind tyrosine-phosphorylated sub-
strates, they would be expected to promote ZAP-70 associa-
tions with already phosphorylated LAT molecules; they
would not be expected to promote LAT’s initial phosphor-
ylation by ZAP-70. Consequently, the molecular basis for
the initial phosphorylation of LAT by ZAP-70 in the ab-
sence of CD4 and CD8 coreceptors remains uncertain.
In conclusion, this study documents the association of
LAT with CD4 and CD8 coreceptor molecules in resting
T cells and thymocytes, and documents that coengagement
of coreceptor molecules with surface TCR results in tyro-
sine phosphorylation of LAT and recruitment of down-
stream signaling mediators.
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Figure 5. Model for the role of coreceptor-associated molecules in
TCR signal transduction. Coengagement of TCR and CD4/CD8 core-
ceptor molecules by MHC–peptide complexes induces the physical ap-
proximation of coreceptor-associated Lck molecules within TCR aggre-
gates, resulting in efficient tyrosine phosphorylation of TCR ITAMs,
recruitment of ZAP-70, and efficient tyrosine phosphorylation of TCR-
associated ZAP-70 molecule. In addition, coengagement of TCR and
CD4/CD8 coreceptor molecules by MHC–peptide complexes also in-
duces the physical juxtaposition of coreceptor-associated LAT molecules
within TCR aggregates, promoting the efficient tyrosine phosphorylation
of LAT by TCR-associated ZAP-70 molecules. Coreceptor-associated
tyrosine-phosphorylated LAT molecules are then bound via SH2 domain
interactions by downstream mediators of TCR signal transduction. In this
model, CD4/CD8 coreceptors perform two important functions in TCR
signal transduction: colocalization of TCR with Lck, and colocalization
of TCR with LAT. We think that these two coreceptor functions are
mediated by individual coreceptor molecules that are associated either
with Lck or with LAT, but alternative stoichiometries are possible.1524 LAT Association with CD4 and CD8 Coreceptors
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